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Abstract
Introduction: Induced sputum is widely used in clinical practice and scientific
studies. This technique has become enormously useful in assessment of airway
inflammation. However, some asthmatics are unable to expectorate sputum of
sufficient quality and quantity necessary for further processing, therefore not
providing reliable results. This research study aimed to examine whether asthma
control and asthma quality of life influence the results of sputum induction.
Material and methods: Fourty-seven adult subjects, current non-smokers with
symptomatic asthma, were studied. All participants underwent clinical
assessment, skin prick testing, spirometry and sputum induction. Before sputum
induction, subjects were asked to fill in the Mini Asthma Quality of Life
Questionnaire (MiniAQLQ) and Asthma Control Questionnaire (ACQ).
Results: Twenty-nine (62%) subjects produced sputum eligible for processing.
This group had a significantly lower ACQ score (0.83 ±0.65 vs. 1.37 ±0.77; 
p = 0.02), higher MiniAQLQ total score (5.67 ±0.99 vs. 4.86 ±1.07; p = 0.011),
higher MiniAQLQ symptoms domain score (5.54 ±1.13 vs. 4.63 ±1.24; p = 0.013)
and higher MiniAQLQ activity limitations domain score (6.08 ±0.92 vs. 5.07 ±1.37;
p = 0.014). The noted differences between groups of patients were not only
statistically but were clinically important.
Conclusions: The study results suggest that successful sputum induction may
be expected in patients with better asthma control and better quality of life.
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Introduction
Induced sputum as a method of assessing airway inflammation was
described for the first time by Pin et al. in 1992 [1]. Since that time interest
in this technique has increased enormously, mainly thanks to its non-
invasive character and safety [2-5]. Cellular and biochemical sputum
examinations have become important instruments of studying airway
inflammation in asthma and other lung conditions. The Medline search
of abstracts containing the key words asthma and induced sputum
identifies more than 1000 articles published to date. This confirms that
induced sputum has become one of the most widely used research tools
in the study of airway inflammation in asthmatics. 
Non-invasive techniques developed for evaluation of airway inflammation
include exhaled nitric oxide (FeNO), exhaled breath condensate (EBC) and
induced sputum. Among these research methods, only induced sputum
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allows the study of cellular and biochemical
components of the inflammatory process in the
respiratory tract. The aim of sputum induction is to
collect an adequate sample of secretions from lower
airways in subjects who do not produce sputum
spontaneously. Despite advances in this technique
since its first description [2], some asthmatics are
unable to expectorate sputum of sufficient quality
and quantity necessary for further processing. This
is an important limitation of this method. Samples
adequate for evaluation are often not obtained,
unlike other materials for studying airway
inflammation in different non-invasive tools, for
example FeNO and EBC. So far there are scarce data
about characteristics of patients according to the
results of sputum induction. 
We decided to investigate, using standardized
and validated questionnaires [6, 7], whether asthma
control and asthma related quality of life influence
the results of sputum induction. 
Material and methods
Study population
Currently non-smoking adults with symptomatic
asthma (n  = 47), defined according to GINA
guidelines [8], with positive reversibility test and/or
demonstrated airway hyperresponsiveness in
methacholine challenge, were studied. Participants
were recruited from the asthmatics referred to the
Outpatient Clinic of the Department of Pneumo  -
nology and Allergy at the Norbert Barlicki Memorial
Teaching Hospital No. 1 in Lodz, Poland. The study
was approved by the Ethics Committee of the
Medical University of Lodz. All patients gave written
informed consent. 
Design
Recruited patients in stable condition, defined as
a disease without exacerbation for at least 1 month,
underwent clinical assessment, skin prick testing,
spirometry and sputum induction. Before sputum
induction, all subjects were asked to fill in the Mini
Asthma Quality of Life Questionnaire (MiniAQLQ)
and Asthma Control Questionnaire (ACQ). 
Skin prick tests
Skin prick testing (SPT) was performed on the
volar surface of the arm on normal skin using
commercial extracts (Allergopharma, Reinbeck,
Germany) according to international guidelines [9].
Subjects were tested for 11 aeroallergens (Derma -
tophagoides pteronyssinus, Dermato pha goides  fari -
nae, grass, birch, hazel, alder, Artemisia, cat and dog
dander, Alternaria alternata and Cladosporium) plus
negative (physiological saline) and positive
(histamine) controls. The results were measured 
15 min after application, and the mean wheal
diameter was calculated and recorded. The test was
considered positive if the mean wheal diameter was
≥ 3 mm than the saline control. Data were excluded
if the saline control was ≥ 3 mm, the histamine
control was < 3 mm, or if the difference of
histamine minus saline was < 3 mm.
Spirometry
Spirometry assessment was performed using
the Lungtest 1000 spirometer (MES, Cracow, Poland)
according to ATS/ERS guidelines [10]. FEV1 (forced
expiratory volume in 1 s), FVC (forced vital capacity)
and FEV1/FVC % were evaluated.
MiniAQLQ and ACQ
MiniAQLQ is a shorter, simpler and more
practical version of the Asthma Quality of Life
Questionnaire (AQLQ) [6]. This questionnaire
measures the impact of asthma on a patient’s
quality of life. It consists of 15 questions in four
domains (symptoms, activity limitations, emotional
function and environmental stimuli). The minimal
important difference (MID) that is considered as
clinically important for MiniAQLQ is 0.5 on the 
7-point scale. The higher the score in MiniAQLQ, the
better quality of life of a patient.
Asthma Control Questionnaire measures the
adequacy of asthma control [7]. It consists of 
7 questions. It includes the 5 most important
symptoms, one question about rescue medication
use and one about actual FEV1 % predicted value.
The minimal important difference (MID) that is
considered as clinically important for ACQ is 0.5 on
the 7-point scale. The lower the score in ACQ, the
better asthma control of a patient.
Sputum induction
The sputum induction procedure was performed
by a trained technician using the method described
previously [2]. Briefly, after salbutamol pre-
treatment, aerosols of hypertonic saline at 3%, 4%
and 5% were each inhaled for 7 min via an UltraNeb
3000 ultrasonic nebulizer (DeVilbiss, USA) with an
output of 1 ml/min. Patients were asked to cough
into a container after each cycle. The procedure was
monitored by spirometry assessments at baseline
and after each saline inhalation. If there was a fall
in FEV1 of ≥ 20% vs. baseline, the procedure was
discontinued. Fall in FEV1 of 10-19% was an
indication to continue the induction with the same
concentration of saline. 
Sputum was selected from the expectorate and
processed within 2 h as described previously [2, 11].
Successful induction was defined as that in which
non-squamous total and differential cell counts
were obtained, squamous cell contamination was
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< 20% and cell viability was > 40% [4], and un  -
successful if subject failed to expectorate sputum
or produced inadequate samples.
Data analysis 
Results were expressed as mean ± standard
deviation (SD). Normally distributed data were
analysed using an unpaired two-sided t-test,
whereas data without a normal distribution were
analysed by Mann-Whitney U-test and χ2 test.
Values of p < 0.05 were considered significant. The
package Statistica 8.0 (Tulsa, USA) was used for all
analyses.
Results
Sputum induction was successful in 29 out of 
47 subjects (success rate 62%). There was no
difference between groups of patients with
successful and unsuccessful induction according to
age, disease duration, atopy, spirometry results or
use of inhaled corticosteroids (ICS). Lack of smoking
history was associated with failure of sputum
induction (Table I). The group of patients with
successful induction had a significantly lower ACQ
score (0.83 ±0.65 vs. 1.37 ±0.77; p = 0.02) (Figure 1).
MiniAQLQ total score was significantly higher in
this group (5.67 ±0.99 vs. 4.86 ±1.07; p = 0.011). In
2 out of 4 domains of MiniAQLQ we also observed
significant differences, namely higher MiniAQLQ
symptoms domain score (5.54 ±1.13 vs. 4.63 ±1.24;
p = 0.013) and higher MiniAQLQ activity limitations
domain score (6.08 ±0.92 vs. 5.07 ±1.37; p = 0.014)
(Figure 2). All differences mentioned above in ACQ
and MiniAQLQ between groups met criteria for
a clinically significant difference (≥ 0.5 point). 
Discussion
To our knowledge, this is the second study to
evaluate the characteristics of patients with asthma
according to the results of sputum induction. In the
previous study, the authors found that failure of
sputum induction was significantly associated with
long-standing disease and the absence of
a smoking history [12].
To examine the possible influence of asthma
control and asthma quality of life on the results of
sputum induction, we used ACQ and MiniAQLQ.
These questionnaires have been fully validated for
use in both clinical practice and clinical trials and
are precise measurement instruments able to
Parameter Successful  Unsuccessful  Value 
induction induction of p
Number 29 18
of subjects
Age [years] 40.2 (14.3) 36.8 (15.2) 0.35
Gender/female,  17 (58.62) 13 (72.22) 0.34
n (%)
Disease duration  5.18 (7.98) 2.83 (3.78) 0.39
[years]
Atopy [%]* 19 (65.5) 12 (66.6) 0.94
FEV1 % predicted 91.51 (11.66) 91.77 (7.65) 0.93
FVC % predicted 102.76 (11.19) 100.67 (8.03) 0.49
FEV1/FVC % 75.8 (9.32) 77.74 (5.78) 0.51
Use of ICS [%] 17 (58.62) 10 (55.55) 0.83
Dose of ICS  631 (743.1) 530 (813.9) 0.52
[μg/day]†
Ever smoking [%] 18 (62.06) 5 (27.77) 0.02
Pack-years‡ 3.97 (5.79) 1.5 (3.2) 0.036
Table I. Patients’ characteristics according to the
results of sputum induction
Values are given as mean (SD) or n (%), *defined as sensitization to at
least 1 allergen in SPT, †equivalent to CFC-beclomethasone dipropionate,
‡for ex-smokers only
2.5
2.0
1.5
1.0
0.5
0
p = 0.02
MID
Figure 1. ACQ score according to the results of
sputum induction
white bar – successful induction, grey bar – unsuccessful
induction, black dashed line – cut-off point defining well-
controlled asthma in ACQ = 0.75 point, MID – minimal
important difference in ACQ – considered as clinically
important difference = 0.5 point
7
6
5
4
3
2
1
0
p = 0.011 p = 0.013 p = 0.014
Figure 2. MiniAQLQ and its domains score according
to the results of sputum induction
white bar – successful induction, grey bar – unsuccessful
induction, MID – minimal important difference in MiniAQLQ
– considered as clinically important difference = 0.5 point
MiniAQLQ Symptoms Activity Emotional Environmental
total MID MID limitations  function stimuli  MID
MID
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detect small but clinically important changes that
patients experience as a result of treatment or
natural fluctuation in their asthma [6, 7]. 
The mean ACQ score of patients with successful
induction was 0.83 and is very close to the cut-off
point defining well-controlled asthma in this
questionnaire. For clinical practice, this cut-off point
is established as ≤ 0.75 point [7]. In the group of
patients with unsuccessful induction, the mean
ACQ score was much higher, reaching 1.37 points.
This difference was not only statistically significant,
but also clinically important (Figure 1). These results
prove that better asthma control correlates with
success in sputum induction. We noted that
patients who underwent successful sputum
induction also had a higher score in MiniAQLQ.
Differences in total score, symptoms and activity
limitations domains of this questionnaire were
statistically significant. We also observed that
differences in total score and 3 out of 4 domains of
MiniAQLQ met criteria for clinically important
(Figure 2). These findings confirm the association
of better quality of life of an asthmatic and
successful sputum induction. The results obtained
in our study invariably demonstrate that patients
with better asthma control and better quality of life
may be expected to produce good quality sputum
after induction. In other words, asthmatics with
worse asthma control and worse quality of life are
less likely to undergo successful sputum induction. 
This is the first study to show that asthma control
and asthma quality of life are important factors
influencing the success or failure of sputum
induction. What is interesting, other variables such
as age, disease duration, atopy, use of ICS or severity
of disease measured by spirometry (FEV1 % predicted)
do not play a role in this matter. In the previous study,
the authors found an association between duration
of asthma and absence of smoking history with
failure of sputum induction [12]. Our study confirmed
the finding that lack of a smoking history is an
independent factor of a failure of sputum induction,
but we did not observe that longer disease duration
plays the same role (Table I). 
Uncontrolled asthmatics have an increased
number of eosinophils in the induced sputum. Results
of induced sputum (cell counts, mainly eosinophil
count) may be useful in daily clinical practice to guide
the intensity of anti-asthmatic treatment with ICS. It
is well known that ICS decrease airway eosinophilia,
which usually leads to better asthma control, while
in contrast asthma exacerbation leads to a rise in
eosinophil level. Clinical assessment of asthmatics
using induced sputum as a method evaluating airway
inflammation is thought to be more effective in
reducing exacerbations than strategies usually
recommended based on symptoms and sequential
analysis of respiratory function [13]. The observation
that successful sputum induction may be expected
in patients with better asthma control and better
quality of life may encourage its more frequent use
in clinical assessments of such asthmatics to prevent
undertreatment with ICS, which therefore may
prevent disease exacerbation. 
Another speculative conclusion is that it may be
more difficult to study airway inflammation using
induced sputum in asthmatics experiencing disease
exacerbation, because of possible problems in
obtaining good quality sputum after induction. It is
well known that asthma exacerbation results in loss
of disease control and leads to worse quality of life. 
The above results, despite being obtained in
a relatively small group of asthmatics, provide very
interesting and new observations. The present
study conclusions require confirmation in larger
projects in future. 
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